Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a helping hand ease the leap to adult transplant care?

NCT ID NCT06386198

Disease control Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This pilot study tests whether adding a health advocate to the transplant team helps young adults (ages 18-25) who received a liver transplant more than a year ago and are about to move to adult care. The advocate helps address social needs like food insecurity, improves communication with doctors, and coordinates care. The study measures whether this support is acceptable and feasible, and whether it improves patient experience and medication adherence.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Health Advocate (Patient Navigator) - a behavioral intervention providing support with social needs, communication, and care coordination
What this could lead to
If successful, this could establish a support model that helps young liver transplant patients manage their health and transition smoothly to adult care, potentially improving long-term outcomes.
What could go wrong
This is a small pilot study (20 participants) focused on feasibility, not proof of effectiveness. Results may not generalize, and the intervention's impact on clinical outcomes is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Jun 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 25 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patient has received a liver transplant \>1 year ago 2. Study team has screened patient and discussed with the primary transplant practitioner that patient may benefit from the Health Advocate program. 3. Patient has an unmet social risk (e.g., food insecurity) or MLVI \>/= 2.0. 4. Patient will be transferred to adult transplant team in \<6 months. 5. Patient can read and write English or Spanish 6. Patient is between 18-25 years old and can provide informed consent. 7. Patient has a working phone and smart device capable of video and/or audio virtual visits via Zoom. Exclusion Criteria: * Patient has significant cognitive impairment. * Does not meet age criteria * Patient is a ward of the state. * Non-English, non-Spanish speakers. * Non-US residents.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Liver transplant; complications are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Liver transplant; complications

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Children's Healthcare of Atlanta

    RECRUITING

    Atlanta, Georgia, 30345, United States

  • University of California San Francisco

    RECRUITING

    San Francisco, California, 94158, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.